SEC Form 4
|
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |
OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response. . . . . 0.5 |
|
1. Name and Address of Reporting Person* Colen, Fred (Last) (First) (Middle) One Boston Scientific Place (Street) Natick, MA 01760-1537 (City) (State) (Zip) USA |
2. Issuer Name and Ticker or Trading Symbol Boston Scientific Corporation (BSX) 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) |
4. Statement for (Month/Day/Year) December 9, 2002 5. If Amendment, Date of Original (Month/Year) |
6. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer Other Officer/Other Description Senior Vice President and Chief Technology Officer 7. Individual or Joint/Group Filing (Check Applicable Line) X Individual Filing Joint/Group Filing |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
|
1. Title of Security (Instr. 3) |
2. Transaction Date (Month/Day/Year) |
3. Transaction Code | V |
4. Securities Acquired (A) or Disposed (D) Of Amount | A/D | Price |
5. Amount of Securities Beneficially Owned at End ofMonth (Instr. 3 and 4) |
6. Owner- ship Form: Direct(D) or Indirect (I) (Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr. 4) |
|
Common Stock |
|
|
7,962 |
D |
|
|
|
|
|
|
|
|
|
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). (over) SEC 1474 (3-99) |
|
|
|
Colen, Fred - December 2002 |
|
Form 4 (continued) |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
|
1. Title of Derivative Security (Instr. 3) |
2. Conver- sion or Exercise Price of Deri- vative Security |
3. Transaction Date (Month/ Day/ Year) |
4. Transaction Code and Voluntary (V) Code (Instr.8) Code | V |
5. Number of Derivative |
6. Date Exercisable(DE) and Expiration Date(ED) (Month/Day/Year) (DE) | (ED) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr.5) |
9. Number of |
10. |
11. Nature of |
|
Stock Option (Right to Buy) |
$42.5100 |
12/09/2002 |
A | |
(A) 60,000 |
Varies (1) | 12/09/2012 |
Common Stock - 60,000 |
|
60,000 |
D |
|
|
Stock Option (Right to Buy) |
$35.7500 |
|
|
|
Varies (2) | 04/19/2009 |
Common Stock - 25,000 |
|
25,000 |
D |
|
|
Stock Option (Right to Buy) |
$28.3125 |
|
|
|
Varies (3) | 05/09/2010 |
Common Stock - 40,000 |
|
40,000 |
D |
|
|
Stock Option (Right to Buy) |
$17.0000 |
|
|
|
Varies (4) | 07/25/2010 |
Common Stock - 40,000 |
|
40,000 |
D |
|
|
Stock Option (Right to Buy) |
$12.2500 |
|
|
|
Varies (5) | 12/06/2010 |
Common Stock - 150,000 |
|
150,000 |
D |
|
|
Stock Option (Right to Buy) |
$15.8100 |
|
|
|
Varies (6) | 02/27/2011 |
Common Stock - 20,000 |
|
20,000 |
D |
|
|
Stock Option (Right to Buy) |
$17.9800 |
|
|
|
Varies (7) | 07/17/2011 |
Common Stock - 50,000 |
|
50,000 |
D |
|
|
Stock Option (Right to Buy) |
$25.0000 |
|
|
|
Varies (8) | 12/17/2011 |
Common Stock - 25,000 |
|
25,000 |
D |
|
|
|
|
|
|
|
|
|
|
|
|
|
Explanation of Responses :
|
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. |
By: /s/ Lawrence J. Knopf, Attorney-in-fact ________________________________ 12-10-2002 ** Signature of Reporting Person Date Fred A. Colen Page 2 SEC 1474 (3-99) |
|
|
|
Colen, Fred - December 2002 |
|
Form 4 (continued) |
|
FOOTNOTE Descriptions for Boston Scientific Corporation BSX Form 4 - December 2002 Fred Colen One Boston Scientific Place Natick, MA 01760-1537 Explanation of responses: (1) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 9, 2003, 50% on December 9, 2004, 75% on December 9, 2005 and 100% on December 9, 2006, the anniversary date of the grant. (2) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable for 25% of the aggregate amount on April 19, 2000, 50% on April 19, 2001, 75% on April 19, 2002 and 100% on April 19, 2003, the anniversary date of the grant. (3) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on May 9, 2001, 50% on May 9, 2002, 75% on May 9, 2003 and 100% on May 9, 2004, the anniversary date of the grant. (4) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on July 25, 2001, 50% on July 25, 2002, 75% on July 25, 2003 and 100% on July 25, 2004, the anniversary date of the grant. (5) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable in approximately equal annual increments on December 6, 2001, 2002 and 2003, the anniversary date of this grant. (6) Grant to the reporting person of an option to purchase 20,000 shares of common stock of the Company exercisable in annual increments of 5,000 shares each on February 27, 2002, 2003, 2004 and 2005, the anniversary date of the grant. (7) Grant to the reporting person of an option to purchase 50,000 shares of common stock of the Company exercisable in annual increments of 12,500 shares each on July 17, 2002, 2003, 2004 and 2005, the anniversary date of the grant. (8) Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 17, 2002, 50% on December 17, 2003, 75% on December 17, 2004 and 100% on December 17, 2005, the anniversary date of the grant. |
|
Page 3 |